Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001554969-16-000003
Filing Date
2016-09-16
Accepted
2016-09-16 14:29:11
Documents
1
Period of Report
2016-09-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3386
  Complete submission text file 0001554969-16-000003.txt   4725
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Drosos Virginia (Reporting) CIK: 0001554969 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 161889142